CFAM
ABBV icon

Center For Asset Management’s AbbVie ABBV Stock Holding History

Center For Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$481K Buy
1,911
+1
+0.1% +$215 0.21% 96
2026
Q1 		$415K Hold
1,910
– – 0.21% 95
2025
Q4 		$436K Sell
1,910
-3
-0.2% -$683 0.23% 95
2025
Q3 		$443K Buy
1,913
+5
+0.3% +$1.02K 0.24% 87
2025
Q2 		$336K Sell
1,908
-71
-4% -$13.2K 0.21% 89
2025
Q1 		$415K Buy
1,979
+66
+3% +$12.8K 0.25% 84
2024
Q4 		$340K Sell
1,913
-31
-2% -$5.7K 0.22% 85
2024
Q3 		$384K Hold
1,944
– – 0.23% 86
2024
Q2 		$333K Sell
1,944
-152
-7% -$25.2K 0.22% 94
2024
Q1 		$382K Sell
2,096
-252
-11% -$43.4K 0.31% 76
2023
Q4 		$364K Sell
2,348
-353
-13% -$51.5K 0.33% 72
2023
Q3 		$403K Buy
2,701
+1,183
+78% +$174K 0.4% 60
2023
Q2 		$205K Sell
1,518
-3,397
-69% -$498K 0.19% 98
2023
Q1 		$783K Buy
4,915
+20
+0.4% +$3.06K 0.77% 33
2022
Q4 		$791K Buy
4,895
+345
+8% +$52.9K 0.74% 36
2022
Q3 		$611K Sell
4,550
-122
-3% -$17.5K 0.61% 40
2022
Q2 		$716K Buy
4,672
+2,373
+103% +$363K 0.66% 35
2022
Q1 		$373K Buy
2,299
+176
+8% +$25.6K 0.29% 70
2021
Q4 		$287K Buy
2,123
+83
+4% +$9.8K 0.21% 89
2021
Q3 		$220K Sell
2,040
-28
-1% -$3.2K 0.19% 97
2021
Q2 		$233K Buy
2,068
+101
+5% +$11.4K 0.2% 92
2021
Q1 		$213K Buy
1,967
+56
+3% +$5.99K 0.2% 84
2020
Q4 		$205K Buy
+1,911
New +$184K 0.2% 80

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Center For Asset Management's ABBV Position: Q2 2026 in Review

Center For Asset Management increased its AbbVie (ABBV) stake by 0.05% in Q2 2026, buying an estimated $215 and bringing the position to 1,911 shares worth $481K. The position accounts for 0.21% of the portfolio, ranked #96.

Center For Asset Management first reported a position in ABBV in Q4 2020 and has held it in 23 quarters since. The position peaked at $791K in Q4 2022. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Center For Asset Management held 1,911 shares of AbbVie worth $481K as of Q2 2026.
  • Center For Asset Management bought 1 AbbVie share in Q2 2026, an estimated $215.
  • AbbVie made up 0.21% of Center For Asset Management's portfolio in Q2 2026, its #96 holding.
  • Center For Asset Management first reported a position in AbbVie in Q4 2020 and has held it in 23 quarters since.
  • Center For Asset Management's AbbVie position peaked at $791K in Q4 2022.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Center For Asset Management's 13F filing for Q2 2026, filed 27 Jul 2026.